This update clarifies that Sysmex will distribute Affy's diagnostic arrays, not the GeneChip research arrays.
NEW YORK (GenomeWeb News) — Affymetrix has hired Japanese lab diagnostics company Sysmex to sell its GeneChip diagnostic arrays and instruments in Japan, and has enabled the company to develop and market its own in vitro diagnostics based on the GeneChip platform.
The deal gives Sysmex exclusive rights to distribute the diagnostic arrays and instruments in Japan, and could enable it to distribute the products to other countries in Southeast Asia.
Another part of the agreement gives Sysmex non-exclusive rights to use the GeneChip to develop and market its in vitro tests worldwide.
The company currently has tests in the areas of urinalysis, immunochemistry, hematology, and hemostasis, and is now marketing a test to detect lymph node metastases in breast cancer patients.
Financial terms of the agreements were not released.